Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom, ITI to Develop Newborn Screening Test for SCID

NEW YORK (GenomeWeb News) — Sequenom said today that it has formed a research collaboration with the Immune Tolerance Institute under which ITI will use Sequenom's MassArray system to develop a newborn screening test for severe combined immunodeficiency.

ITI is a non-profit organization formed as a partnership with the University of California, San Francisco. The SCID assay is based on the work of UCSF researcher Jennifer Puck. Sequenom said a recent feasibility study has demonstrated "the adaptability of Dr. Puck’s RT-PCR screening assay for SCID diagnosis on the MassArray platform."

ITI CEO Louis Matis said in a statement that SCID is curable by bone marrow transplants if it is detected in time.

Sequenom CEO Harry Stylii said that the newborn screening test would reflect "the broad applicability" of the MassArray, and he described the collaboration as "in line with our goal of increasing Sequenom's reach in the field of molecular diagnostics."

Financial terms of the deal were not disclosed.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.